Humacyte to Present at the TD Cowen 45th Annual Health Care Conference

DURHAM, N.C., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that Laura Niklason, M.D., Ph.D., Founder, President, and Chief Executive Officer, will present at the TD Cowen 45^th Annual Health Care Conference in Boston, MA on Tuesday, March 4, 2025. Management will also be available for one-on-one meetings.

Read more at globenewswire.com